Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Total Knee Arthroplasty
NCT05018091Phase 4Completed
- Sponsor
- Rush University Medical Center
- Start
- Oct 2021
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Rush University Medical Center. Primary endpoint: Opioid Consumption at 48 hours. Started Oct 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05018091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018091.